Kritika Agarwal speaks to The Hindu Business Line on indemnity for vaccine makers

by | Aug 24, 2021

Kritika Agarwal, Associate Partner – Corporate/M&A and Competition spoke to The Hindu Business Line on Indemnity for vaccine makers. According to her, “vaccine manufacturers may not want to spend time and money on defending any claims in all the countries where they supply and be subject to extensive litigation.”

Read the full article here.

More News

Ravi S. Raghavan quoted by Fortune India on Cryptocurrency Tax

Fortune India covered an article on the legality and the taxability of Cryptocurrency in India, following the finance ministry's announcement of Crypto Tax as part of the 2022 Union Budget tabled in parliament. As part of their article, they spoke to Ravi S. Raghavan,...

read more